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Background: The relationship between coronary artery aneurysm (CAA) after sirolimus-eluting stent (SES) implantation and long-term clinical 
events remain unknown. This study assessed the long-term clinical and angiographic findings in patients who developed CAA after SES implantation.
Methods: This study retrospectively analyzed 3613 lesions (2285 consecutive patients) after SES implantation from November 2002 to December 
2006. According to our follow-up protocol of coronary angiography (CAG), early follow-up CAG was scheduled at 3 months for CTO and LMT stenting 
cases, midterm at 8 months, and late at 20 months. Totally, 86% (3131/3613) of the lesions underwent some timings of follow-up, 681 lesions 
underwent early and midterm follow-ups, and 2450 lesions underwent late follow-up. CAA is identified by the size of luminal diameter which is 1.2 
times larger than that of the adjacent reference segments.
Results: The prevalence of CAA after SES implantation was 2.2% (68/3131). The number of CAA was 24 lesions (35%) in LAD, 38 (55%) in RCA, and 
6 (8%) in LCX. The cumulative restenosis rate in CAA was 20% (14/68). The target lesion revascularization rate was 25% (17/68). The incidence of 
stent fracture was 39% (27/68). The incidence of stent thrombosis was significantly higher in the CAA group than in the non-CAA group (7.3% [5/68] 
vs 0.5% [16/3063], p<0.001). CAA increased in size during the follow-up period in 47% (32/68) of the lesions.
Conclusions: After SES implantation, CAA is rare and can be incidentally detected by follow-up CAG. However, CAA could be associated with 
coronary events such as restenosis, stent fracture, and stent thrombosis. Increase in size of CAA after SES implantation may influence the long-term 
clinical adverse events.
